• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY ULTRAFLEX¿ ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513820
Device Problems Partial Blockage (1065); Break (1069); Difficult to Remove (1528)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/23/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation on october 05, 2015 that an uncovered ultraflex esophageal ng stent was implanted during a stent placement procedure performed on (b)(6) 2015.According to the complainant, the stent was implanted to treat a 5mm benign fistula in the proximal esophagus caused by stomach cancer.Reportedly, the patient's anatomy was not tortuous and had not been dilated prior to stent placement.The stent was successfully implanted without issue.On (b)(6) 2015, during a planned stent removal, the physician attempted to remove the stent using a foreign body gripper; however, the stent retention suture broke and the stent was unable to be removed.The physician noted that the difficulty removing the stent was probably due to some noted tissue ingrowth within the stent.On (b)(6) 2015, the physician deployed a wallflex esophageal stent within the previously implanted stent, completing the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be okay.Please note, the uncovered ultraflex esophageal ng stent was not used per the directions for use (dfu).The uncovered ultraflex esophageal ng stent was used to cover a benign fistula and the ultraflex esophageal ng stent system dfu notes the stent is contraindicated for "placement for occlusion of esophageal fistula of any type, unless a covered stent is being used.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX¿ ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
nancy cutino
100 boston scientific way
marlborough, MA 01752
5086834000
MDR Report Key5185283
MDR Text Key29775251
Report Number3005099803-2015-02993
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodeES
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/28/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2016
Device Model NumberM00513820
Device Catalogue Number1382
Device Lot Number17522774
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/05/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/17/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-